The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
Sportradar Group AG
SRAD · Nasdaq · USD · Market cap $3.9B · 4,882 employees
Sportradar Group AG, together with its subsidiaries, provides sports data services for the sports betting and media industries in Switzerland, the United States, North America, Africa, Malta, the Asia Pacific, the Middle…
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-15
Screened 2026-09-15 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Sportradar Group AG holds its Accumulation at $13.31. The statistical read favours the sellers, held for 5 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 5 days |
| Price at the screen | $13.31 |
| Valuation | 221.83 trailing · 29.44 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.58 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 2.19% | Below 33% | Interest-bearing debt is just 2.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 1.42% | Below 33% | Cash held in interest-bearing accounts and securities is 1.4% of assets, under the one-third limit. | Pass |
| Receivables | 15.97% | Below 49% | Money owed to the company is 16.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.75% | Below 5% | Only 0.8% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-15 screen. The gold marker is the market price at the same screen. A 6.3% margin of safety to the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +24% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsThe quiet data feed behind every bet
Picture the referee's whistle that also keeps the score for every bookmaker in the room. Sportradar supplies the sports data that powers betting platforms and media rights, yet the business earns only a 5% profit margin and a 7% return on equity while growing revenue at 11%. At 18 times forward earnings the valuation already prices in steady improvement that the current numbers do not support.
The 40% gap to our fair value looks attractive on paper and the ethical screen is clear, but opportunity rating sits at none. Low returns and thin margins suggest the company lacks a durable edge in a crowded data market, even with twenty-one analysts calling the shares a strong buy.
Currency moves, regulatory shifts on betting and the unknown competitive moat add real volatility that a low-teens growth rate does not offset. The setup is neither compelling nor cheap enough once quality is weighed. Analysis, not advice.
| Forward P/E | 29.4xpriced for continued growth |
| Trailing P/E | 221.8xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.06 |
| EPS, forward | 0.45 |
| Revenue growth | +18.9%steady growth |
| Profit margin | 1.2%barely profitable |
| Return on equity | 2.0%a modest return on shareholder capital |
| FCF yield | 8.82% |
| Debt to equity | 0.08minimal debt: a conservative balance sheet |
| Current ratio | 0.98below 1: short-term bills exceed liquid assets |
| Beta | 1.58much more volatile than the market |
| Short interest, float | 0.13% |
| 52-week range | 11.55 - 31.18 |
| Market cap | $3.9B |
| Employees | 4,882 |
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Switzerland and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSRAD trades on Nasdaq (the company is based in Switzerland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 18.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $12.80 | +30.7% | · | $1,307 | +30.7% |
| 2 months | $15.47 | +8.1% | · | $1,081 | +8.1% |
| 3 months | $19.12 | -12.5% | · | $875 | -12.5% |
| 6 months | $23.14 | -27.7% | · | $723 | -27.7% |
| 1 year | $24.23 | -31.0% | · | $691 | -31.0% |
| 2 years | $10.78 | +55.2% | · | $1,552 | +55.2% |
| 3 years | $12.30 | +36.0% | · | $1,360 | +36.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SRAD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.